Cite
HARVARD Citation
Montesarchio, V. et al. (2020). Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. Journal for immunotherapy of cancer. 8 (2), p. . [Online].